Tag: PGNX
3 Stocks Under $10 With Breakout Potential
After executing perfectly on their business plans in 2016, these three stocks look set to reap the profits in 2017. With buyout potential and higher share prices expected in the New Year, adding these three stocks to your portfolio today looks like a smart move. It is hard to believe 2016 has already come and […]
3 Fast-Growth Stocks With Home Run Potential
With massive growth potential over the next few years and solid floors beneath their share prices, consider these three stocks shared today. All three have recently seen their business prospects brighten and now is a great time to buy. Bret Jensen shares why. The end of 2016 is around the corner, and it has been […]
3 Biotech Stocks Set To Soar Under Republican Leadership
After being the market’s whipping boy for the last year, the biotech sector looks ready to rebound under a pro-business White House. Already, many stocks have shot up over 50%, but Bret Jensen shares three today that still have plenty of upside backed up by strong products already on the market. The biotech sector has […]
6 Undervalued Stocks With Strong Upcoming Catalysts
If all goes well for these six stocks, over the next year they could be worth significantly more than what currently trade for. Each stock has important, business-defining events that, if positive, would make their businesses much more valuable. “Uncertainty is the only certainty there is, and knowing how to live with insecurity is the […]
4 Top Biotech Stocks To Be Purchased On The Cheap
Biotech stocks took a tumble last week, but for the long-term investor these valuations are a gift. Snap up shares of these four promising stocks for a discount today and take advantage of these too-low prices. Last week was brutal for biotech investors. The main indices dropped more than six percent just in Tuesday’s and […]
7 Stocks To Buy In The Market’s Hottest Sectors
Invest in the momentum of these seven stocks spanning three different sectors that all have strong economic tailwinds lifting their revenues, profits, and stock prices higher. As the market continues to flirt with and reach new all-time highs, many sectors in the market seem primed to far outpace their peers. Sometimes being a good investor […]
4 Likely Biotech Takeover Targets To Buy
After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist. It was a good week for the Biotech Gems portfolio. Progenics Pharmaceuticals (NASDAQ: PGNX) leapt 25% in […]
Buy These 3 Takeover Targets For 2016
In my last column, I spoke on how M&A chatter has been increasing in the small and mid-cap names within the biotech sector. The derailment of the huge $150 billion merger between Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) is leading many analysts to put forth a list of names these companies could target as they […]
